Why Viking Therapeutics Stock Perked Up in March
Viking's shares received a boost from a pair of catalysts last month.
Viking Therapeutics
VKTX
$8.37
-$0.35
-4.0%
BATS BZX Real Time Price as of April 24, 2019, 4:30 p.m.
View Interactive VKTX Charts
Viking Therapeutics, Inc.
News & Analysis: Viking Therapeutics
The Fool has written over 100 articles on Viking Therapeutics.
All
Market Moves
Earnings
Here's Why Investors Are Betting Against These 2 Biotech Stocks
Are intrepid short-sellers taking advantage of misguided enthusiasm?
3 Top Value Stocks to Buy Right Now
Bargain hunting? These out-of-favor biotech and e-commerce stocks should appeal to value investors.
Here's What Pushed Viking Therapeutics Higher on Friday
Investors were impressed with updated results for the company's lead candidate.
Viking Therapeutics (VKTX) Q4 2018 Earnings Conference Call Transcript
VKTX earnings call for the period ending December 31, 2018.
3 Stocks That Could Double Your Money
Here's why Wall Street thinks these stocks could generate returns of 100% or more in the next 12 months.
Is Viking Therapeutics a Buy?
Once-sky-high stocks of pharmaceutical companies pursuing treatments for NASH have gotten a lot cheaper, especially this one.
3 Top Biotech Stocks to Buy in February
Here's why Viking Therapeutics, Cambrex, and Sarepta Therapeutics are all solid biotech plays this month.
Here's Why Viking Therapeutics Rose as Much as 13.9% Today
A rival's setback is this small cap's gain, right?
3 Great Stocks Under $10
It's not the low share price that makes these stocks attractive, it's their huge growth prospects.
